Updates and Ongoing Controversies in Hodgkin Lymphoma

Elizabeth BrÃ©m, MD, HS Clinical Assistant Professor, Chao Comprehensive Cancer Center presents Updates and Ongoing Controversies in Hodgkin Lymphoma at the Medical Oncology Association Southern California Spotlight on ASH 2017.

Updates and Ongoing Controversies in Hodgkin Lymphoma

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Updates and Ongoing Controversies in Hodgkin Lymphoma

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia